ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,683
Diagnostic referrals
1,076
Outstanding pathways
351

Screening pathway

  1. Screening5,683Encounters
  2. Positive finding2,019Documented findings
  3. Referral1,076Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 66.

Participant insight

Expanded synthetic participant 0806 · EXP-0806Synthetic · Site B

Full participant history through 2027-12-07, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-01-08
  4. · Diagnostic referral · EXP-0806-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Barrier documented · Contact difficulty
  9. · Contact attempt · Unsuccessful
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-09-04
  15. · Follow-up disposition · Resolved · EXP-0806-T-R
  16. · Screening · HPV DNA · Repeat · Prior VIA positive
  17. · Screening result · HPV DNA · HPV not detected · Adequate
  18. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  19. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0684 · Expanded synthetic participant 0684Site D — Community Engagement Programme
EXP-0686 · Expanded synthetic participant 0686Site B — Peri-Urban Access Programme
EXP-0687 · Expanded synthetic participant 0687Site D — Community Engagement Programme
EXP-0688 · Expanded synthetic participant 0688Site E — Resource-Constrained Navigation Programme
EXP-0689 · Expanded synthetic participant 0689Site D — Community Engagement Programme
EXP-0690 · Expanded synthetic participant 0690Site C — Rural Outreach Programme
EXP-0691 · Expanded synthetic participant 0691Site E — Resource-Constrained Navigation Programme
EXP-0692 · Expanded synthetic participant 0692Site A — Urban Referral Hub
EXP-0693 · Expanded synthetic participant 0693Site E — Resource-Constrained Navigation Programme
EXP-0695 · Expanded synthetic participant 0695Site A — Urban Referral Hub
EXP-0696 · Expanded synthetic participant 0696Site E — Resource-Constrained Navigation Programme
EXP-0697 · Expanded synthetic participant 0697Site D — Community Engagement Programme
EXP-0698 · Expanded synthetic participant 0698Site D — Community Engagement Programme
EXP-0699 · Expanded synthetic participant 0699Site A — Urban Referral Hub
EXP-0700 · Expanded synthetic participant 0700Site B — Peri-Urban Access Programme
EXP-0702 · Expanded synthetic participant 0702Site D — Community Engagement Programme
EXP-0703 · Expanded synthetic participant 0703Site C — Rural Outreach Programme
EXP-0704 · Expanded synthetic participant 0704Site A — Urban Referral Hub
EXP-0705 · Expanded synthetic participant 0705Site E — Resource-Constrained Navigation Programme
EXP-0706 · Expanded synthetic participant 0706Site D — Community Engagement Programme
EXP-0707 · Expanded synthetic participant 0707Site A — Urban Referral Hub
EXP-0708 · Expanded synthetic participant 0708Site B — Peri-Urban Access Programme
EXP-0710 · Expanded synthetic participant 0710Site C — Rural Outreach Programme
EXP-0711 · Expanded synthetic participant 0711Site E — Resource-Constrained Navigation Programme
EXP-0712 · Expanded synthetic participant 0712Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1970
HPV DNA
2986
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.